Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications-Reference-Cited by-同舟云学术

Advances in engineered nanosystems: immunomodulatory interactions for therapeutic applications

Published:2024 Issue:27 Volume:16 Page:12820-12856
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Khatua Rupam¹^ORCID,Bhar Bibrita¹,Dey Souradeep²^ORCID,Jaiswal Chitra¹,J Victoria¹,Mandal Biman B.¹²³^ORCID

Affiliation:

1. Biomaterials and Tissue Engineering Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati – 781039, Assam, India

2. Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati – 781039, Assam, India

3. Jyoti and Bhupat Mehta School of Health Sciences and Technology, Indian Institute of Technology Guwahati, Guwahati – 781039, Assam, India

Abstract

This review extensively explores immunomodulatory nanomedicines, focusing on their unique properties and critical design strategies for interacting with immune components for various therapeutic applications.

Funder

Department of Science and Technology, Ministry of Science and Technology

Department of Biotechnology, Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/NR/D4NR00680A

Reference284 articles.

1. The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness

2. The role of the complement system in cancer

3. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions

4. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy

5. Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells